Reference priceEUR €170.50Original source price: INR 15,500.00. Converted estimates are available by currency selection.
| Brand | Otulfi |
|---|---|
| Manufacturer | Fresenius Kabi Deutschland GmbH |
| Prescription required | Yes |
Otulfi 45mg/0.5ml Single-dose Vial 1 x 0.5ml(ustekinumab) (ustekinumab-aauz)
ustekinumab-aauz
Description
Otulfi 45mg/0.5ml Single-dose Vial 1 x 0.5ml(ustekinumab) (ustekinumab-aauz) is a medicine catalog record in the MediPriceHub database. Active ingredient: ustekinumab-aauz. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Fresenius Kabi Deutschland GmbH. Therapeutic category: Medicine Library > Dermatology Medicines > Drugs for psoriasis. Pack information: 45 / 0.5. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
OTULFI is a human interleukin-12 and -23 antagonist indicated for the treatment of: Adult patients with: Pediatric patients 6 years and older with: • moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy. • active psoriatic arthritis (PsA) . • moderately to severely active Crohn's disease (CD) . • moderately to severely active ulcerative colitis. • moderate to severe plaque psoriasis (PsO) , who are candidates for phototherapy or systemic therapy. • active psoriatic arthritis (PsA) .How to Use
Use ustekinumab-aauz under the supervision of a qualified healthcare professional. It should be prepared and administered only by trained healthcare professionals in a setting appropriate for injectable or infusion medicines. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: ustekinumab-aauz. Pack size: 45 / 0.5. Pack unit: bottle. Manufacturer: Fresenius Kabi Deutschland GmbH. Origin country: United States. Source category: Medicine Library > Dermatology Medicines > Drugs for psoriasis. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.Esta información es solo orientativa. Consulta a un profesional sanitario antes de usar cualquier medicamento.